Literature DB >> 22373591

Management of children exposed to multidrug-resistant Mycobacterium tuberculosis.

James A Seddon1, Peter Godfrey-Faussett, Anneke C Hesseling, Robert P Gie, Nulda Beyers, H Simon Schaaf.   

Abstract

Children exposed to multidrug-resistant (MDR) Mycobacterium tuberculosis are at risk of developing MDR tuberculosis. Where treatment is available, it is lengthy, expensive, and associated with poor adherence and notable morbidity and mortality. Preventive treatment effectively lowers the risk of disease progression for contacts of individuals with drug-susceptible tuberculosis, but this strategy is poorly studied for contacts of people with MDR tuberculosis. In this Review we discuss the management of child contacts of source cases with MDR tuberculosis. We pay particular attention to assessment, existing international guidelines, possible preventive treatments, rationales for different management strategies, and the interaction with and implications of HIV infection.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22373591     DOI: 10.1016/S1473-3099(11)70366-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  17 in total

1.  Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.

Authors:  Stephanie Thee; Anthony J Garcia-Prats; Heather R Draper; Helen M McIlleron; Lubbe Wiesner; Sandra Castel; H Simon Schaaf; Anneke C Hesseling
Journal:  Clin Infect Dis       Date:  2014-10-30       Impact factor: 9.079

2.  Xpert MTB/RIF on Stool Is Useful for the Rapid Diagnosis of Tuberculosis in Young Children With Severe Pulmonary Disease.

Authors:  Elisabetta Walters; Marieke Magrieta van der Zalm; Megan Palmer; Corné Bosch; Anne-Marie Demers; Heather Draper; Pierre Goussard; Hendrik Simon Schaaf; Sven Olaf Friedrich; Andrew Whitelaw; Robin Warren; Robert P Gie; Anneke C Hesseling
Journal:  Pediatr Infect Dis J       Date:  2017-09       Impact factor: 2.129

3.  Epidemiology of childhood tuberculosis in Switzerland between 1996 and 2011.

Authors:  Gabriela Oesch Nemeth; Johannes Nemeth; Ekkehardt Altpeter; Nicole Ritz
Journal:  Eur J Pediatr       Date:  2013-11-08       Impact factor: 3.183

4.  Concordance of resistance profiles in households of patients with multidrug-resistant tuberculosis.

Authors:  Jonathan B Parr; Carole D Mitnick; Sidney S Atwood; Katiuska Chalco; Jaime Bayona; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2013-10-28       Impact factor: 9.079

5.  Why do child contacts of multidrug-resistant tuberculosis not come to the assessment clinic?

Authors:  K Zimri; A C Hesseling; P Godfrey-Faussett; H S Schaaf; J A Seddon
Journal:  Public Health Action       Date:  2012-09-21

6.  Decentralised care for the management of child contacts of multidrug-resistant tuberculosis.

Authors:  J A Seddon; A C Hesseling; R Dunbar; H Cox; J Hughes; K Fielding; P Godfrey-Faussett; H S Schaaf
Journal:  Public Health Action       Date:  2012-09-21

7.  Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.

Authors:  Amber Arnold; Graham S Cooke; Onn Min Kon; Martin Dedicoat; Marc Lipman; Angela Loyse; Irina Chis Ster; Thomas S Harrison
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 8.  Updated diagnosis and treatment of childhood tuberculosis.

Authors:  Shou-Chien Chen; Kwo-Liang Chen; Kou-Huang Chen; Shun-Tien Chien; Kow-Tong Chen
Journal:  World J Pediatr       Date:  2013-02-07       Impact factor: 2.764

9.  Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis.

Authors:  Mercedes C Becerra; Soumya Swaminathan
Journal:  J Public Health Policy       Date:  2014-09-11       Impact factor: 2.222

10.  Setting priorities for a research agenda to combat drug-resistant tuberculosis in children.

Authors:  B Velayutham; D Nair; S Ramalingam; C M Perez-Velez; M C Becerra; S Swaminathan
Journal:  Public Health Action       Date:  2015-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.